Serum endoglin as a marker in hepatocellular carcinoma
Introduction Hepatitis C viral (HCV) infection is a major risk factor for liver cirrhosis, liver failure, and hepatocellular carcinoma (HCC). A number of laboratory-based methods has been developed for the noninvasive diagnostic evaluation of HCC. Endoglin (CD105) is a homodimeric membrane glycoprot...
Saved in:
Main Authors: | Rehab A Mohamed (Author), Hend M Maghraby (Author), Eman M Abd El Salam (Author), Hala M Nageb (Author), Eman E Ahmad (Author), Nagwa A Mohamed (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Maternal serum endoglin as an early marker of pre-eclampsia in high-risk patients
by: Elhawary TM, et al.
Published: (2012) -
Serum Golgi protein-73 in combination with α-fetoprotein for diagnosing hepatocellular carcinoma in Egyptian patients
by: Mohamed M Makhlouf, et al.
Published: (2017) -
Prognostic value of serum autotaxin in liver cirrhosis and prediction of hepatocellular carcinoma
by: Nagwa Ramadan Ahmed, et al.
Published: (2019) -
Role of serum micro-RNA 486-5p in Egyptian cirrhotic hepatitis C patients with hepatocellular carcinoma
by: Amany N. Abbasy, et al.
Published: (2024) -
Soluble Endoglin Serum Level is Higher in Preeclampsia Compared to Molar and Normal Pregnancy
by: Maya K. Puspitasari, et al.
Published: (2014)